SHSE:688806 ()
Â
Ordinary Shares - Class A
Â¥
20.72
-0.95 (-4.38%)
Sep 10
Business Description
Zhuhai Trinomab Pharmaceutical Co Ltd
ISIN : CNE100007WN7
Share Class Description:
SHSE:688806: Ordinary Shares - Class ACompare
Compare
Traded in other countries / regions
688806.China IPO Date
2026-07-21Description
Zhuhai Trinomab Pharmaceutical Co Ltd is a biopharmaceutical company engaged in the development, production and sales of fully human antibody drugs.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.74 | |||||
Equity-to-Asset | 0.11 | |||||
Debt-to-Equity | 6.71 | |||||
Debt-to-EBITDA | -1.28 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.74 | |||||
Beneish M-Score | 7.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 70.1 | |||||
3-Year EBITDA Growth Rate | 15.9 | |||||
3-Year EPS without NRI Growth Rate | 16.4 | |||||
3-Year FCF Growth Rate | 11.7 | |||||
3-Year Book Growth Rate | -53.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.63 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 1.14 | |||||
Days Inventory | 962.99 | |||||
Days Sales Outstanding | 586.34 | |||||
Days Payable | 812.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.8 | |||||
Shareholder Yield % | -2.77 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 43.51 | |||||
Operating Margin % | -1129.78 | |||||
Net Margin % | -1173.88 | |||||
EBITDA Margin % | -1061.17 | |||||
FCF Margin % | -1175.92 | |||||
OCF Margin % | -1132.28 | |||||
ROE % | -247.1 | |||||
ROA % | -62.91 | |||||
ROIC % | -110.62 | |||||
3-Year ROIIC % | -100.38 | |||||
ROC (Joel Greenblatt) % | -247.53 | |||||
ROCE % | -99.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 155.79 | |||||
PB Ratio | 76.74 | |||||
Price-to-Tangible-Book | 82.88 | |||||
EV-to-EBIT | -17.52 | |||||
EV-to-EBITDA | -18.81 | |||||
EV-to-Revenue | 199.56 | |||||
EV-to-FCF | -16.97 | |||||
Earnings Yield (Greenblatt) % | -5.71 | |||||
FCF Yield % | -6.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhuhai Trinomab Pharmaceutical Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 51.225 | ||
| EPS (TTM) (Â¥) | -1.56 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 27.5 | ||
| 14-Day ATR (Â¥) | 1.763214 | ||
| 20-Day SMA (Â¥) | 24.702 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (Â¥) | 20.71 - 52.52 | ||
| Shares Outstanding (Mil) | 460.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhuhai Trinomab Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhuhai Trinomab Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhuhai Trinomab Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhuhai Trinomab Pharmaceutical Co Ltd(SHSE:688806)'s stock price today?
The current price of SHSE:688806 is ¥20.72. The 52 week high of SHSE:688806 is ¥52.52 and 52 week low is ¥20.71.
When is next earnings date of Zhuhai Trinomab Pharmaceutical Co Ltd(SHSE:688806)?
The next earnings date of Zhuhai Trinomab Pharmaceutical Co Ltd(SHSE:688806) is .
Does Zhuhai Trinomab Pharmaceutical Co Ltd(SHSE:688806) pay dividends? If so, how much?
Zhuhai Trinomab Pharmaceutical Co Ltd(SHSE:688806) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers